Eculizumab 300 MG Injection: Warning and Precautions

Eculizumab (Brand Name: Soliris) 300 mg is a monoclonal antibody that binds to complement protein C5 and blocks terminal complement activation. The eculizumab injection is approved to treat patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and some forms of generalized myasthenia gravis and neuromyelitis optica spectrum disorder. In patients taking treatment with this […]

Soliris (Eculizumab Injection) Dosage, and Side Effects

Background: Soliris (Eculizumab Injection) is a medicine launched for the treatment of patients with paroxysmal nocturnal haemoglobinuria (PNH), generalised myasthaenia gravis (GMG), atypical haemolytic uraemic syndrome (aHUS), and neuromyelitis optica spectrum disorder (NMOSD). The medication is developed and manufactured by the US based pharmaceutical company Alexion Pharmaceuticals, a subsidiary of AstraZeneca. It was given orphan […]

Access to specialty products in India

Indian Pharma Network helps in accessing new products in India. These products are launched and approved recently in USA or Europe but yet to be approved in India. We help in accessing these new launches through named patient import.

Contact Us

Indian Pharma Network provides consultancy in connecting patients with companies operating in Medical tourism.

Indian Pharma Network.
info@indianpharmanetwork.in
Contact Us
Indian Pharma Network.
905 – 9th Floor, I-Thum Business Park,
Tower A, Plot no. A-40, Unit no. 5,
Sector-62, Noida 201301,
+ 91-9650877511
info@indianpharmanetwork.in
1